Skip to main content
Premium Trial:

Request an Annual Quote

Nova Southeastern Wins $2M NINDS Award to Study Biomarkers of Chronic Fatigue Syndrome

NEW YORK (GenomeWeb) – Scientists at Nova Southeastern University's Institute for Neuro-Immune Medicine will use a $2 million grant from the National Institute of Neurological Disorders and Stroke to study complex biomarkers of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in men, NSU said today.

ME/CFS, a debilitating complex disorder that causes profound fatigue, is worsened by physical and mental activity and is four times more likely to occur in women than men. It impacts several body systems, and symptoms include weakness, muscle pain, impaired memory and/or concentration, and insomnia. It affects more than 1 million Americans.

In the study, lead investigator Professor Mary Ann Fletcher will head efforts to understand the underlying mediators of the disorder, and to pinpoint mechanisms that may be used to develop more targeted treatments. Her team has already developed a dynamic model to identify the mediators of the disorder's persistence and relapse. They now plan to use the model to map the mediators of genomic, cellular, and chemical response, in particular by comparing responses in men with those in women.

"Our goal is to pin down precisely what are the differences between men and women facing these diseases and to develop more effective and specific treatment plans using existing drugs that are currently being used to treat other related conditions and symptoms," Fletcher said in a statement.

Because ME/CFS flare-ups often occur during physical activity, the researchers plan to investigate biomarkers before, during, and after an exercise protocol by drawing blood multiple times. The team then will use computational biology models to target the root causes of the disease.

With this grant, Fletcher and her team have now received a total of nearly $10 million from NIH, the US Department of Defense, and the Department of Veterans Affairs to study ME/CFS and Gulf War Illness, a related neuro-immune disorder that presents with similar symptoms but shows different gene activation responses and cytokine signatures.

Fletcher and her team plan to combine their findings from this study with the other ME/CSF and GWI research projects to identify differences in responses between genders and to develop tailored treatments for both men and women.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.